ClosedHealth & Human Services
Strengthening HIV Treatment, Laboratory Services, Medication Assisted Therapy, and Program Monitoring in Ukraine under the President's Emergency Plan for AIDS Relief (PEPFAR)
Centers for Disease Control - CGHCDC-RFA-GH21-2143
Description
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,000,000 for Year 1, subject to the availability of funds.
The HIV epidemic in Ukraine predominantly impacts key populations (KPs) with the largest burden among people who inject drugs (PWID) and men who have sex with men (MSM). There are approximately 220,000 people living with HIV (PLHIV) in Ukraine. PEPFAR has been providing technical support to Ukraine to scale up index testing and for sexual and needle-sharing partners, social network testing, and increased access to pre-exposure prophylaxis (PrEP) and medicated assisted therapy for PWID. PEPFAR has also been supporting improved access to World Health Organization (WHO) recommended first line antiretroviral therapies (ARTs) and delivery strategies to improve retention and viral suppression. This NOFO will create an enabling policy environment and full implementation of the HIV electronic data entry system (HIV MIS). The strategies include providing technical assistance (TA) for HIV testing and treatment providers to enhance care and treatment, to create a National Medical Assisted Therapy (MAT) Hub to ensure government leadership in MAT scale up and enhance laboratory capacity. The assistance provided will ensure national level strengthening of surveillance, research, and epidemiology (SRE) by focusing on improved HIV case-based, mortality, surveillance, epidemic modelling, routine KP cascade based on program and medical data, and HIV drug resistance (DR). All activities will build capacity and contribute to achieving 95-95-95 targets and maintain epidemic control in Ukraine.
CFDA Number
93.067
Funding Instrument
Cooperative Agreement
Funding Level
Federal
Jurisdiction
US
Cost Sharing
No
Open Date
March 29, 2021
Close Date
May 28, 2021
Posted Date
March 29, 2021
Eligible Applicant Types
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Tags
HHS-CDC-CGHCFDA:93.067Cooperative AgreementHealth
Related Health & Human Services Grants
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
0d left
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health
0d left
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
0d left
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
National Institutes of Health
0d left